{"name": "Talima Therapeutics", "permalink": "talima-therapeutics", "crunchbase_url": "http://www.crunchbase.com/company/talima-therapeutics", "homepage_url": "http://www.talima.com", "blog_url": "", "blog_feed_url": "", "twitter_username": "", "category_code": "biotech", "number_of_employees": null, "founded_year": null, "founded_month": null, "founded_day": null, "deadpooled_year": null, "deadpooled_month": null, "deadpooled_day": null, "deadpooled_url": null, "tag_list": "", "alias_list": "", "email_address": "info@talima.com", "phone_number": "650.331.7246", "description": "drug delivery company", "created_at": "Sat Sep 12 07:50:12 UTC 2009", "updated_at": "Wed Sep 01 12:47:50 UTC 2010", "overview": "\u003Cp\u003ETalima Therapeutics is an emerging drug delivery company dedicated to the development of novel products that increase patient choice and improve quality of life. With a unique approach to therapy, we design customized drug-delivery systems that optimize the local therapeutic performance and reduce the undesired systemic side effects enabling us to address unmet needs or underserved markets. We foster a collaborative environment and strive for excellence internally and with our partners. \u003C/p\u003E\n\n\u003Cp\u003EOur lead product is currently in Phase I/II clinical testing for the treatment of onychomycosis, a fungal disease of the nails and we are in the process of planning its pivotal trials. \u003C/p\u003E", "image":  {"available_sizes":    [[[136,       65],      "assets/images/resized/0005/9562/59562v1-max-150x150.jpg"],     [[136,       65],      "assets/images/resized/0005/9562/59562v1-max-250x250.jpg"],     [[136,       65],      "assets/images/resized/0005/9562/59562v1-max-450x450.jpg"]],   "attribution": null}, "products":  [], "relationships":  [], "competitions":  [], "providerships":  [], "total_money_raised": "$21M", "funding_rounds":  [{"round_code": "b",    "source_url": "http://venturebeat.com/2007/05/29/talima-therapeutics-raises-19m-for-site-specific-drugs/",    "source_description": "Talima Therapeutics raises $19M for site-specific drugs",    "raised_amount": 19000000.0,    "raised_currency_code": "USD",    "funded_year": 2007,    "funded_month": 5,    "funded_day": 29,    "investments":     [{"company": null,       "financial_org":        {"name": "US Venture Partners",         "permalink": "us-venture-partners"},       "person": null},      {"company": null,       "financial_org":        {"name": "Latterell Venture Partners",         "permalink": "latterell-venture-partners"},       "person": null},      {"company": null,       "financial_org":        {"name": "De Novo Ventures",         "permalink": "de-novo-ventures"},       "person": null}]},   {"round_code": "unattributed",    "source_url": "",    "source_description": "Cap Funding Report",    "raised_amount": 2000000.0,    "raised_currency_code": "USD",    "funded_year": 2005,    "funded_month": 4,    "funded_day": 1,    "investments":     [{"company": null,       "financial_org":        {"name": "De Novo Ventures",         "permalink": "de-novo-ventures"},       "person": null},      {"company": null,       "financial_org":        {"name": "Palo Alto Investors",         "permalink": "palo-alto-investors"},       "person": null}]}], "investments":  [], "acquisition": null, "acquisitions":  [], "offices":  [{"description": "HQ",    "address1": "75 Shoreway Road ",    "address2": "Suite C ",    "zip_code": "94070",    "city": "San Carlos",    "state_code": "CA",    "country_code": "USA",    "latitude": 37.520295,    "longitude": -122.260647}], "milestones":  [], "ipo": null, "video_embeds":  [], "screenshots":  [], "external_links":  []}